All Pharma News
price-trendAsk Us
Cash-strapped eye disease biotech halves portfolio

Cash-strapped eye disease biotech halves portfolio
Gabrielle Masson FIERCE BIOTECH
08 Aug 2023
Share Share
Groundbreaking trial underway to improve vision in individuals with RP

Groundbreaking trial underway to improve vision in individuals with RP
PR NEWSWIRE
14 Feb 2023
Share Share
Kiora Pharmaceuticals concludes subject enrolment in PCED therapy trial

Kiora Pharmaceuticals concludes subject enrolment in PCED therapy trial
CLINICAL TRIALS ARENA
05 Jan 2023
Share Share
Kiora Pharmaceuticals Announces Publication of Pha1 Trial Results for KIO-100

Kiora Pharmaceuticals Announces Publication of Pha1 Trial Results for KIO-100
PRESS RELEASE
17 Oct 2022
Share Share
Kiora Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

Kiora Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
PRESS RELEASE
13 Oct 2022
Share Share
Kiora gets approval to begin Phase Ib retinitis pigmentosa trial

Kiora gets approval to begin Phase Ib retinitis pigmentosa trial
CLINICALTRIALSARENA
30 Jun 2022
Share Share
EyeGate Pharma Completes Enrollment in PII Proof-of-Concept Study for PP-001

EyeGate Pharma Completes Enrollment in PII Proof-of-Concept Study for PP-001
GLOBENEWSWIRE
08 Sep 2021
Share Share
EyeGate Appointment of Brian M. Strem, Ph.D., as President and CEO

EyeGate Appointment of Brian M. Strem, Ph.D., as President and CEO
GLOBENEWSWIRE
26 Jul 2021
Share Share
EyeGate Pharma Announces 1st Patient Dosed for PP-001 in a Phase 2 study

EyeGate Pharma Announces 1st Patient Dosed for PP-001 in a Phase 2 study
OPHTHALMOLOGY TIMES
14 Jun 2021
Share Share
EyeGate Reports Q1 2021 Financial Results and Provides Business Update

EyeGate Reports Q1 2021 Financial Results and Provides Business Update
GLOBENEWSWIRE
12 May 2021
Share Share